PhytoPharmica Inc., headquartered in the United States, is a leading player in the herbal supplement industry, specialising in high-quality botanical products. Founded in the early 1990s, the company has established itself as a trusted name in natural health, focusing on the development and distribution of innovative herbal formulations. With a commitment to quality and sustainability, PhytoPharmica offers a diverse range of products, including herbal extracts, vitamins, and dietary supplements. Their unique formulations are crafted using advanced extraction techniques, ensuring maximum potency and efficacy. Recognised for their dedication to research and development, PhytoPharmica has achieved significant milestones, positioning itself as a market leader in the natural health sector. The company continues to expand its operational reach, serving customers across North America and beyond, while maintaining a strong focus on promoting holistic wellness.
How does PhytoPharmica Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
PhytoPharmica Inc.'s score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PhytoPharmica Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, PhytoPharmica Inc. may inherit climate commitments and emissions data from its parent organisation; however, no specific details or figures have been provided. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. In the broader context of the industry, many companies are increasingly adopting science-based targets and committing to net-zero emissions, which may influence PhytoPharmica Inc.'s future climate commitments.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
PhytoPharmica Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
